Porous orthopedic materials coated with demineralized bone matrix

Patent metadata

Field	Value
Publication number	US-9849214-B2
Application number	US-201514636487-A
Country	US
Kind code	B2
Filing date	Mar 3, 2015
Priority date	Mar 21, 2007
Publication date	Dec 26, 2017
Grant date	Dec 26, 2017

Abstract

A biomaterial including a porous biocompatible structure having interconnected pores, wherein the pores have interior walls and are interconnected by passageways, the interior walls and passageways being coated with an osteoinductive aqueous demineralized bone extract solution, the aqueous demineralized bone extract solution including growth factors, proteins, a demineralized bone matrix and at least one of a weak acid and a guanidine hydrochloride, wherein the demineralized bone matrix is present per 100 g of the solution in an amount of from about 2 g to about 10 g.

First claim

What is claimed is:

1. A biomaterial comprising:
a porous biocompatible structure comprising interconnected pores, wherein the pores comprise interior walls and are interconnected by passageways;
an aqueous demineralized bone extract coating comprising growth factors, proteins or a combination thereof, wherein the aqueous demineralized bone extract coating is formed by dissolving soluble demineralized bone matrix in an aqueous solution comprising at least one of a weak acid or guanidine hydrochloride; and
a demineralized bone gelatin coating comprising a demineralized bone matrix gelatin comprising demineralized bone matrix suspended in an aqueous saline solution, wherein the aqueous saline solution is heated to dissolve the demineralized bone matrix to form the demineralized bone matrix gelatin;
wherein the demineralized bone extract coating and the demineralized bone gelatin coating cover the interior walls and passageways.

2. The biomaterial of claim 1 , wherein the aqueous demineralized bone extract coating and the demineralized bone gelatin coating are combined into a single coating material which covers the interior walls and passageways.

3. The biomaterial of claim 1 , wherein the aqueous demineralized bone extract coating covers the interior walls and passageways and the demineralized bone gelatin coating covers the aqueous demineralized bone extract coating.

4. The biomaterial of claim 1 , wherein the aqueous demineralized bone extract coating and the demineralized bone gelatin coating are dried on the interior walls and passageways.

5. The biomaterial of claim 1 , wherein the aqueous demineralized bone extract coating is an acid soluble demineralized bone coating.

6. The biomaterial of claim 1 , wherein the aqueous demineralized bone extract coating is a guanidine hydrochloride demineralized bone extract.

7. The biomaterial of claim 1 , wherein the porous biocompatible structure comprises a porous metal, hydroxyapatite or xenograft demineralized cancellous bone.

8. The biomaterial of claim 7 , wherein the porous metal is stainless steel, titanium, a titanium alloy, tantalum or a cobalt-chromium alloy.

9. The biomaterial of claim 7 , wherein the hydroxyapatite comprises tricalcium phosphate.

10. The biomaterial of claim 7 , wherein the hydroxyapatite comprises a coralline hydroxyapatite.

11. The biomaterial of claim 1 , wherein the pores have a size of from about 5 microns to about 1000 microns.

12. The biomaterial of claim 1 , wherein the pores have an average diameter of from about 200 microns to about 500 microns.

13. The biomaterial of claim 1 , wherein the biomaterial has a form of granules, blocks, cylinders or pre-formed shapes.

14. The biomaterial of claim 1 , wherein the biomaterial is used as an orthopedic implant.

15. An orthopedic implant comprising:
a porous biocompatible structure comprising interconnected pores, wherein the pores comprise interior walls and are interconnected by passageways and wherein the pores have an average diameter of from about 200 microns to about 500 microns;
an aqueous demineralized bone extract coating comprising growth factors, proteins or a combination thereof, wherein the aqueous demineralized bone extract coating is formed by dissolving soluble demineralized bone matrix in an aqueous solution comprising at least one of a weak acid or guanidine hydrochloride; and
a demineralized bone gelatin coating comprising demineralized bone matrix suspended in an aqueous saline solution, wherein the aqueous saline solution is heated to dissolve the demineralized bone matrix to form the demineralized bone matrix gelatin;
wherein the demineralized bone extract coating and the demineralized bone gelatin coating covers the interior walls and passageways, wherein the bone extract coating is dried on the interior walls and passageways.

16. The orthopedic implant of claim 15 , wherein the porous biocompatible structure is coral line hydroxyapatite.

17. The orthopedic implant of claim 15 , wherein the demineralized bone extract is an acid soluble extract.

18. The orthopedic implant of claim 15 , wherein the demineralized bone extract is a guanidine hydrochloride demineralized bone extract.

19. The biomaterial of claim 15 , wherein the demineralized bone gelatin coating and the demineralized bone extract are combined into a single coating material which covers the interior walls and passageways.

20. The biomaterial of claim 15 , further comprising a demineralized bone gelatin coating, wherein the demineralized bone extract coating covers the interior walls and passageways and the demineralized bone gelatin coating covers the demineralized bone extract coating.

Assignees

• Biomet Mfg Llc

Inventors

• Woodell-May Jennifer
• Troxel Karen

Classifications

• A61L27/58

  Materials at least partially resorbable by the body · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title

• A61L27/042

  Iron or iron alloys · CPC title

• A61L31/10

  Macromolecular materials · CPC title

• A61L31/124

  of other specific inorganic materials not covered by A61L31/122 or A61L31/123 · CPC title